Cargando…

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non-alcoholic steatohepatitis (NASH); the risk of cirrhosis and hepatocellular carcinoma (HCC) increases when fibrosis is present. N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vallianou, Natalia, Christodoulatos, Gerasimos Socrates, Karampela, Irene, Tsilingiris, Dimitrios, Magkos, Faidon, Stratigou, Theodora, Kounatidis, Dimitris, Dalamaga, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774162/ https://www.ncbi.nlm.nih.gov/pubmed/35053205 http://dx.doi.org/10.3390/biom12010056

Ejemplares similares

Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2023)

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Mycobiome and Cancer: What Is the Evidence?
por: Vallianou, Natalia, et al.
Publicado: (2021)

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
por: Dalamaga, Maria, et al.
Publicado: (2021)

Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence
por: Vallianou, Natalia, et al.
Publicado: (2021)

Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients
por: Karampela, Irene, et al.
Publicado: (2023)

Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study
por: Karampela, Irene, et al.
Publicado: (2022)

Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study
por: Christodoulatos, Gerasimos Socrates, et al.
Publicado: (2021)

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health
por: Karampela, Irene, et al.
Publicado: (2022)

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
por: Amanatidou, Evropi, et al.
Publicado: (2022)

Prediabetes screening: Questionable benefits in the golden years
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Diverting epithelial-to-mesenchymal transition to transform cancer cells to adipocytes: A promising strategy to stop metastasis
por: Dalamaga, Maria, et al.
Publicado: (2019)

SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19
por: Tsilingiris, Dimitrios, et al.
Publicado: (2022)

A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer
por: Bader-Larsen, Karlen Stade, et al.
Publicado: (2021)

The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery
por: Liu, Junli, et al.
Publicado: (2022)

Comment to: Are fetuin-A levels beneficial for estimating timing of sepsis occurrence?
por: Karampela, Irene, et al.
Publicado: (2019)

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
por: Karampela, Irene, et al.
Publicado: (2020)

Serum bilirubin to fetuin-A ratio as a prognostic biomarker in critically ill patients with sepsis
por: Karampela, Irene, et al.
Publicado: (2021)

The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
por: Vallianou, Natalia G., et al.
Publicado: (2023)

Diet and Exercise in the Treatment of Fatty Liver
por: Magkos, Faidon, et al.
Publicado: (2012)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Does COVID-19 Involve the Retina?
por: Karampelas, Michael, et al.
Publicado: (2020)

Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
por: Dalamaga, Maria, et al.
Publicado: (2020)

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19
por: Dalamaga, Maria, et al.
Publicado: (2020)

Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studies()
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Putative Factors That May Modulate the Effect of Exercise on Liver Fat: Insights from Animal Studies
por: Magkos, Faidon
Publicado: (2012)

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19
por: Kritis, Panagiotis, et al.
Publicado: (2020)

Hepatic Steatosis as a Marker of Metabolic Dysfunction
por: Fabbrini, Elisa, et al.
Publicado: (2015)

Could hyperglycemia-induced cardiac autoimmunity be hidden behind cardiovascular disease in type 1 diabetes mellitus?
por: Vallianou, Natalia, et al.
Publicado: (2019)

The Gut Microbiome Profile in Obesity: A Systematic Review
por: Castaner, Olga, et al.
Publicado: (2018)

One day of overfeeding impairs nocturnal glucose but not fatty acid homeostasis in overweight men
por: Magkos, Faidon, et al.
Publicado: (2013)

Fermented Foods in the Management of Obesity: Mechanisms of Action and Future Challenges
por: Jalili, Mahsa, et al.
Publicado: (2023)

Adipose tissue monomethyl branched chain fatty acids and insulin sensitivity: effects of obesity and weight loss
por: Su, Xiong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vv3ebt2s1cr8vo91t068ho98c6